STAT

Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome

Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug? Find out on the latest episode of "The Readout…

Can biopharma police itself? Who decides whether something’s a disease or a difference? And will fecal matter ever become a drug?

We discuss all that and more on the latest

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da STAT

STAT1 min lettiMedical
STAT+: Pharmalittle: U.S. Considers Giving Half-doses Of Moderna Vaccine; Americans May Not Get AstraZeneca Shot Until April
The U.S. government is considering giving some people half the dose of the Moderna Covid-19 vaccine in order to speed vaccinations.
STAT1 min letti
STAT+: Pharmalittle: Hospitals Grapple With Extra Dose Of Pfizer Vaccine; FDA Panel Meets To Review Moderna Vaccine
With the Covid-19 vaccine in short supply, hospital pharmacists found themselves throwing away one in every six doses of the first vaccines distributed this week in the U.S.
STAT1 min lettiMedical
STAT+: Pharmalittle: Novavax Faces Raw-materials Shortages For Covid-19 Shot; India Curbs Vaccine Exports
Novavax is delaying signing a contract to supply its Covid-19 vaccine to the European Union because the company is struggling to source raw materials.